INS and Alzheimer disease: Concurrently, neurons and neurotransmission, insulin signaling, and carbohydrate metabolism pathways were upregulated in AD mice treated with iMGL‐EVs and downregulated in hNSC‐EV‐treated AD mice compared to vehicle AD.